News
GLP-1's, which are traditionally diabetes medications, have exploded in popularity since they were approved for weight-loss.
Eli Lilly stock crashes as late-stage data for weight-loss pill falls short of expectations. Analyst explains why data wasn't ...
US stocks trimmed losses on Thursday, finishing mixed after President Trump's sweeping tariffs hit dozens of US trade ...
Live Updates Live Coverage Updates appear automatically as they are published. Discovery-ing Some Profits 9:40 am Continuing ...
The main indexes finished well off their session highs after a disappointing batch of corporate earnings reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results